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A stem-cell leukemia associated usually with erythroblastosis can be induced 
rapidly  (<  100 days) and in high incidence in rats with a  set of pulse-doses of 
homogenates  of  7,  12-dimethylbenz(a)anthracene  (1)  and  7,  8,  12-trimethyl- 
benz(a)anthracene  (TMBA) 1 (2).  It is characteristic  of this  type  of stem-cell 
leukemia that exuberant growth of leukemic cells occurs in the sinusoids of the 
liver  and  there  is  terminal  hepatic  insufficiency.  The  thymus,  however,  is 
notably free of leukemic involvement.  Specific chromosome abnormalities occur 
in bone marrow cells of leukemic rats  (3-5). 
In the present study a  sequence of morphologic and biochemical events was 
followed during the evolution of leukemia in Long-Evans (L-E) rats. In addition 
to structural  changes, the concentrations of phosphatases  and dehydrogenases 
were determined. The earliest sign of leukemia was found in the spleen. 
Alkaline phosphatase is a characteristic enzyme of the polymorphonuclear leukocyte 
series of most mammalian species  (6).  This enzyme occurs in myelocytes and mature 
polymorphonuclear leukocytes; it is not present in lymphocytes or cells of the erythroid 
series.  Alterations in alkaline phosphatase activity have been demonstrated in some 
human leukemias (7-10). 
Acid phosphatase occurs in high concentration in erythrocytes (11,  12). Changes in 
acid phosphatase activity in erythrocytes have been described in certain hematological 
disorders (13). 
A  high  rate  of aerobic  and  anaerobic  glycolysis is  a  metabolic  characteristic  of 
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rapidly growing malignant tumors (14). In tumors of rodents, Meister (15) found that 
the concentration of lactate dehydrogenase (LDH)  much exceeded that found in the 
normal tissue of origin. In the hyperplasias and neoplasia of the mammary gland of 
rodents,  Rees and Huggins  (16)  found concentrations of both LDH  and malate de- 
hydrogenase (MDH) were rather similar and both exceeded by an order of magnitude 
that of other pyridine nucleotide-llnked enzymes which they measured: in the mam- 
mary hyperplasia of advanced pregnancy and lactation MDH  >  LDH; in mammary 
cancer LDH  >  MDH. 
Materials and Methods 
Male L-E rats were used for all experiments. The animals have been bred at random inter se 
for 12 yr in our closed colony. They were housed in metal cages in air-conditioned rooms at 
25  ° 4- 2°C, fed a commercial ration (Rockland Mouse/Rat  Diet,  Teklad, Inc.,  Monmouth, 
I11.), and given water ad libitum. Hepatic biopsy was performed under ether anesthesia with 
aseptic precautio1~s. 
A lipid emulsion  2 containing 7, 8, 12-TMBA, 0.5%  (w/v), was prepared by the method of 
Sehurr (17). The emulsion was injected in a caudal vein; the day of first injection is designated 
day 0. 
Heparinized blood for hematological studies was obtained by cardiac puncture. Leukocytes 
and erythrocytes were counted electronically (Coulter Counter Model Z, Coulter Electronics~ 
Inc.,  Hialeah,  Fla.).  Hemoglobin  content  was  measured  spectrophotometrically after  the 
method of Drabkin and Austin (18). 
Tissues for conventional morphological studies were preserved in Bouin's fixative and paraf- 
fin sections stained with hematoxylln and eosin. Tissues for alkaline phosphatase histochemis- 
try were fixed  in ice-cold  (4°C)  absolute acetone. Paraffin sections were stained by Gomori 
technique (19) ;  one-half of the section was counterstained with eosin and the other half with 
hematoxylin and eosln. 
For enzyme studies rats were decapitated and tissues excised rapidly and weighed. Tissues 
were homogenized in an ice-cold solution (2 ml) of 0.15 N NaC1 containing 0.003 ~  NaHCOa 
and kept at 4°C  thereafter. Homogenization was performed with Willems Polytron Homog- 
enizer (Brinkmann Instruments, Inc., Westbury, N. Y.). The homogenate was centrifuged at 
13,000 g for 20 min in a  refrigerated centrifuge and the supernatant used for enzyme assay. 
Spectrophotometric determinations were made with a Beckman Model DU spectrophotometer 
(Beckman Instruments, Inc., Fullerton, Calif.) using optical cells with 1 cm light path. 
Alkaline phosphatase (orthophosphoric monoester phosphohydrolase, E.C.3.1.3.1.)  activity 
was measured in barbital buffer, pH 9.3,  using p-nitrophenyl phosphate as substrate as pre- 
viously  described  (20).  Acid  phosphatase  (orthophosphoric  monoester  phosphohydrolase, 
E.C.3.l.3.2)  activity was similarly measured using 0.1 M sodium acetate buffer, pH 5.1.  One 
unit of enzyme is defined as the enzyme activity which liberated 1 #mole of p-nitrophenol in 30 
rain at 38°C. 
Lactate  dehydrogenase (L-lactate: nieotinamide adenine dinueleotide  [NAD]  oxidoreduc- 
tase, E.C.1.1.1.27)  and maiate dehydrogenase (L-malate: NAD oxidoreductase, E.C.1.1.1.37) 
activities were measured concurrently (16). The initial velocity of  the reaction was measured 
under conditions which yielded zero order kinetics. One unit of LDH  or MDH is defined as 
the  enzyme  activity  which  resulted  in  oxidation  of  1 #mole of  NADH in 1 rain at 25°C. 
All of the enzyme units are expressed in terms of 1 g wet weight of tissue. 
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Protein content was measured by the method of Lowry et al. (21). The results are expressed 
as g/100 g wet weight of tissue. The results were subjected to statistical evaluation and signifi- 
cant differences  between the means (P <  0.05) are given. 
RESULTS 
Characteristics  of Leukemia in L-E Rat.--Leukemia  was evoked in a  group 
of male L-E rats with four or five intravenous pulse-doses of 7, 8,  12-TMBA, 
30-35 mg/kg,  at  10-day intervals, beginning at age 28  days. Hepatic biopsy 
was performed to confirm leukemia at least 10 days before enzyme assay. 
TABLE I 
Hematological and Anatomical Findings in Mate Rats With Leukemia* 
Leukemia  Con  trol  P 
Body weight g  154  ±  38  294  4- 26  <0.01 
Hemoglobing/100cc  11.2  4-  3.1  14.7  4-  1.5  <0.01 
Leukocytes X 103/mm  3  19.40  4- 11.27  7.94  4-  2.68  <0.01 
Erythrocytes  X 106/mm  3  5.02  :t:  1.43  7.18  4-  1.27  <0.01 
Liverg/100g  6.84  4-  3.28  3.22  4-  0.14  <0.01 
Spleen g/100 g  0.370 4-  0.211  0.184 4-  0.023  <0.05 
Thymus g/100 g  0.031 4-  0.012  0.065 4-  0.010  <0.01 
Lymph nodes (3) g/100 g  0.014 4-  0.005  0.005 4-  0.001  <0.01 
Adrenalglands (2) g/100 g  0.033 ±  0.016  0.013 4-  0.003  <0.05 
* Leukemia was evoked in 12 male rats with four or five intravenous pulse-doses of 7, 8, 12- 
TMBA, 30-35 mg/kg, at 10-day intervals beginning at age 28 days. Autopsy was performed 
at age 97 4- 20 days. 10 untreated control male rats were autopsied at age 110 -4- 11 days. 
Mean values with standard deviation are given. 
Anatomical and hematologicalfindings:  In early leukemia the rats were active 
and appeared healthy although somewhat reduced in size compared with un- 
treated controls. When leukemia was advanced, there was marked reduction in 
body  weight,  the  animals became  hunched,  and  their  coats  lacked  normal 
luster. Progressive anemia occurred with advancing leukemia and  there was 
reduction in numbers of  circulating erythrocytes  (Table I).  In most animals 
advanced leukemia was associated with leukocytosis, usually of moderate grade 
(Table I). But in early leukemia the number of circulating leukocytes in many 
instances was  in normal range or leukopenia was present. With leukocytosis 1288  LEUKEMIA  IN  SPLEEN 
there appeared in the peripheral blood large atypical mononuclear cells,  12-20 
/~ in diameter,  and many erythroblasts some of which were atypical. Plasma 
alkaline phosphatase  activity in leukemic rats was  reduced from the normal 
control value of 4.9  4-  0.7  units/ml  plasma  to  2.0  4-  0.6  units  (P  <  0.01). 
Well  and Russell  (22)  have shown that plasma  alkaline phosphatase  activity 
in rats  can be greatly reduced by fasting,  only the ingestion of unsaturated 
fatty acids of certain types will restore plasma phosphatase activity to normal. 
FIG. 1.  Leukemic stem cell infiltration of splenic red pulp (L). Malpighian corpuscle (MC) 
is not involved. Hematoxylin and eosin. X 320. 
Leukemic rats showed moderate enlargement of the spleen (Table I) which 
developed a  smooth capsular surface and was frequently studded with one or 
more irregular pale nodules 1-8 mm in diameter. In the terminal stages the liver 
was  greatly  enlarged,  granular,  and  friable;  the  thymus  was  atrophied  but 
lymph nodes and adrenal glands were somewhat increased in size. 
Histologically, the hepatic sinusoids and red pulp of spleen were massively 
infiltrated with  leukemic  stem  cells  but  malpighian  corpuscles  were not  in- 
volved (Fig. 1). Leukemic stem cells consisted of large mononuclear cells with 
vesicular nuclei, one or several prominent dark nucleoli, and variable amounts COLIN  BIRD  AND  CHARLES  HUGGINS  1289 
of basophilic cytoplasm; they were admixed usually with erythroblasts. Similar 
small leukemic deposits were found in lymph node sinuses and adrenal cortex. 
The thymus, however, was notably free of leukemic infiltration. 
Biochemical  findings:  Enzyme levels were determined in  the  spleens of  12 
leukemic male rats age 82-145 days and 10 untreated male controls of compar- 
able age. The results obtained have been repeatedly confirmed in other groups 
of animals. 
As previously described (23) it has been found useful to relate the activity of 
LDH 
LDH and MDH measured concurrently as a quotient: Q  MD-H" In the spleen 
of the normal  adult male rat,  the activity of MDH  exceeded that of LDH, 
LDH 
thus Q  MDH  -  <  1. In leukemia LDH activity in the spleen was increased 
LDH 
while MDH activity was reduced, thus Q  MDH-  >  1 (Table II). 
TABLE II 
Phosphatase and Dehydrogenase Enzymes in Spleen of Male Rats With Leukemia* 
Phosphatase  Dehydrogenase 
Group  Protein 
pH 5.1  pH 9.3  LDH  MDtt  Q  LDH 
MDH 
Leukemia  196.3  4-  31.4:~  15.3  4-  11.5§  107.9  4- 24.4~  91.l  ~-  13.2:~  1.20  q- 0.28:~  10.1  4- 0.9 
Control  233.0  4-  21.3  6.0  4- 2.6  83.2  4- 4.3  124.2  4- 9.1  0.67  4- 0.06  10.5  -4-  1.8 
* Leukemia was evoked in 12 male rats with four or five intravenous pulse-doses of 7, 8, 12-TMBA, 30-35 mg/kg, at 
10-day intervals beginning at age 28 days. Autopsy was performed at age 97 4- 20 days.  10 untreated control male rats 
were autopsied at age 110 4-11 days. Enzyme activity  is  expressed in units per gram wet weight of tissue as defined. Pro- 
tein levels are expressed as grams per 100 gram wet weight of tissue. Mean values with  standard deviation are given. 
~t P  <  0.01. 
§ P  <  0.05. 
Acid phosphatase activity in the spleen was significantly reduced in leukemia 
whereas  alkaline  phosphatase  was  increased.  Histochemically  there  was  a 
modest increase in nonleukemic alkaline phosphatase-positive myelopoietic loci 
in  the  red pulp but leukemic stem  cells were  completely devoid of alkaline 
phosphatase  activity. By contrast, in myelogenous leukemia, the spleen con- 
tains numerous alkaline phosphatase-positive leukemic cells (Fig.  2). Normal 
adult rats rarely contain substantial numbers of myelopoietic foci in the spleen. 
There were no significant differences in levels of protein in the  spleens of 
leukemic  rats  compared  with  controls  (Table  II),  so  that  enzyme activity 
expressed as specific activity (units per milligram of protein) showed no sig- 
nificant differences from enzyme activity expressed in terms of wet weight of 
tissue. 
Initial Effects  of Pulse-Doses  of 7, 8, 12-TMBA.--Groups  of male rats were 1290  LEUKEMIA  IN  SPLEEN 
given a  series of intravenous pulse-doses of 7, 8,  12-TMBA, 30-35 mg/kg,  at 
10-day intervals,  beginning  at  age 28 days.  A  group was killed 3  days after 
each pulse-dose of hydrocarbon. For comparison, groups of untreated male rats 
were sacrificed at intervals of 10 days. 
Anatomical and hematological effects: After the first dose of hydrocarbon, there 
was no decline in body weight,  but retardation of growth occurred after the 
second and subsequent doses. After each injection of hydrocarbon there  was a 
FIG. 2. Myelogenous  leukemia in rat spleen Numerous alkaline phosphatase-positive  leu- 
kemic cells  are present in red pulp (ML). Malpighlan  corpuscle (MC) is not involved.  Gomori's 
alkaline phosphatase reaction counterstained  with eosin. X 150. 
characteristic  decline  in  circulating  leukocytes  affecting  both  polymorpho- 
nuclear leukocytes and lymphocytes; recovery to preinjection levels before the 
next pulse-dose of hydrocarbon has been previously described (2). In the normal 
weanling  rat,  moderate  anemia  was  a  normal  physiological  occurrence  and 
hemoglobin  content  progressively increased  towards  adult  levels  concurrent 
with normal sexual maturation  (Table III). A  series  of pulse-doses of hydro- 
carbon  prevented  normal  hematological  development  and  moderate  anemia 
persisted (Table III). Reiterated pulse-doses of 7, 8, 12-TMBA also prevented 
normal  growth of the thymus in which  there was  depletion  of  lymphocytes, COLIN  BIRD  AND  CHARLES  I]UGGINS 
TABLE  III 
Hematological and Anatomical Findings in Male Rats Receiving Series  of 
Pulse-Doses of 7, 8, 12-TMBA* 
1291 
Mean  Group  Day  body  Hemoglobin  Leukocytes X  Thymus 
weight  g/10O  ce  10~/mm3  Liver g/100 g  Spleen  g/100 g  g/100 g 
g 
Control  0  53  9.5  -4-  1.0  5.0  q-  1.0  4.13  4- 0.26  0.41  ±  0.07  0.30  4-  0.05 
7, 8, 12-TMBA  3  66  10.3  4- 0.8  4.0  ±  0.7  4.10  4- 0.21  0.31  -4-  0.05:~  0.19  -4- 0.04:~ 
Control  10  86  11.9  ±  1.0  8.0  4-  1.4  4.08  -4- 0.12  0.44  4- 0.08  0.28  4-  0.07 
7, 8, 12-TMBA  13  99  10.4  4-  1.2§  3.7  4-  1.0J;  4.32  4.  0.33  0.24  4.4- 0.03:~  0.19  4.  0.04~ 
Control  20  143  12.1  -4- 0.7  7.1  4-  1.7  4.13  ~-  0.24  0.34  4-  0.09  0.24  4.4- 0.05 
7, 8, 12-TMBA  23  120§  11.9  4-  1.5  2.4  4-  1.0J;  4.29  4.  0.31  0.21  4.  0.02:~  0.16  4- 0.07§ 
Control  30  163  13.4  4.  0.3  7.1  4-  2.0  3.55  4.  0.24  0.31  -4- 0.04  0.20  4- 0.04 
7, 8, 12-TMBA  34  140§  10.4  4-  1.2~  2.1  4- 0.8:[:  3.94  ±  0.20~  0.18  4- 0.03~  0.13  -4- 0.02:~ 
* A group of 32 male rats received pulse-doses of 7, 8, 12-TMBA, 30-35  mg/kg, at intervals of 10 days beginning at age 
28 days (day 0). Eight rats were sacrificed 3 days after each pulse-dose of hydrocarbon.  Controls  consisted of groups of 
eight untreated male littermates sacrificed on each of the days hydrocarbon was injected. Mean values with .~tandard de- 
viation are given. 
P  <  0.01. 
§ P  <  0.03. 
FIG. 3.  Hyperplastic  stem-cell  nodules  (N)  in  subcapsular  zone  of  spleen,  containing  ery- 
throblastic  elements.  Hematoxylin  and  eosin.  X  50. 1292  LEUKEMIA  IN  SPLEEN 
but growth of the liver was virtually unaffected except for a slight increase in 
its relative weight. 
Initially, atrophy of the spleen followed successive doses of 7, 8,  12-TMBA. 
Lymphoid elements were especially affectedwith reduction in size of malpighian 
corpuscles and mantle zones. The earliest morphological evidence of incipient 
leukemia in spleen comprised focal aggregation of large mononuclear stem cells 
in the red pulp. These cells either formed a collar around malpighian  corpuscles 
Fla. 4. Proliferating  stem cells (SC) in splenic red pulp. Note numerous  mitoses. Lymphoid 
elements of malpighian  corpuscle  (MC) adjacent. Hematoxylin  and eosin. X 510. 
or when situated in the subcapsular areas of spleen caused formation of wedge- 
shaped nodules (Fig. 3). Variable numbers of such nodules, 1-4 mm in diameter, 
were found in half of the spleens after the third and fourth injections of hydro- 
carbon.  The  proliferating  stem  cells  were  identical  morphologically  with 
leukemic stem cells and were admixed with variable numbers of erythroblasts 
(Fig. 4). Alkaline phosphatase staining showed that stem cells were devoid of 
enzyme activity and  only an occasional small  positive myelocytic focus was 
found in the adjacent areas of red pulp. No stem-cell foci were found in liver 
at this stage and splenic changes preceded hepatic changes. 
Biochemical effects:  In the spleens of normal rats, acid phosphatase activity COLIN  BIRD  AND  CHARLES  ItUGGINS  1293 
greatly exceeded alkaline phosphatase activity (Tables II and IV). Further, in 
the normal weanling rat, alkaline phosphatase activity in the spleen exceeded 
by severalfold that of the adult animal; with increasing maturity a progressive 
reduction of enzyme occurred (Table  IV).  The spleen  of the immature rat 
exhibits  considerable  histological  evidence of hemopoietic activity in the red 
pulp (erythro- and myelopoiesis); during puberty this activity diminishes con- 
current with the disappearance of "physiological anemia." Alkaline phosphatase 
activity in the spleen is restricted to the endothelium of small blood vessels 
together with Inyeloid elements  (myelocytes and  polymorphonuclear leuko- 
cytes) in the red pulp (Fig. 5). Thus, disappearance of myeloid elements froln 
TABLE  IV 
Phosphata*e and Dehydrogenase Enzymes in Spleen of Male Ra~.s Receiving Series of 
Pulse-Doses of 7, 8, 12-TMBA* 
Group  Day 
Phosphatase  Dehydrogenase 
-  LDH 
pH 5.1  pH 9.3  LDH  MDH  (2 MDH 
Control  0  173.9  4-  15.2  19.7  4-  10.2  88.0  4-  7.2  109.1  4- 9.5  0.81  4- 0.04 
7, 8, 12-TMBA  3  190.7  4-  14.2§  21.5  4- 9.0  98.1  4-  11.2§  127.4  4-  12.9:~  0.77  4- 0.07 
Control  10  154.8  4- 9.2  17.0  -4-  8.1  85.8  4-  10.9  110.7  4-  13.9  0.78  4- 0.04 
7, 8, 12-TMBA  13  191.6  4- 9.35  11.2  4- 3.7  94.7  4-  6.7  132.6  4-  11.6:~  0.72  4- 0.07 
Control  20  163.0  4-  13.3  13.4  4- 4.3  94.0  4-  15.4  127.6  4-  18.3  0.74  4- 0.02 
7, 8, 12-TMBA  23  208.8  4-  27.41:  14.9  4- 3.8  100.3  4-  7.1  139.5  4-  8.3  0.72  4-  0.05 
Control  30  175.4  4-  13.6  9.8  4-  2.4  100.2  4- 9.9  139.5  :[:  18.0  0.72  4- 0.04 
7, 8, 12-TMBA  34  221.4  4-  14.7:~  11.7  4-  1.4  101.6  4-  5.2  148.7  4-  18.2  0.69  4-  0.06 
* Groups of eight male rats were sacrificed 3 days after receiving pulse-doses of 7, 8, 12-TMBA, 30-35 mg/kg, 
at 10-day intervals beginning at age 28 days (day 0).  A group of eight untreated control male littermates were 
sacrificed at each of the days hydrocarbon was given. Enzyme activity is expressed as units per gram wet weight 
of tissue as defined. Mean values with standard deviation are given. 
P  <  0.01. 
§ P  <  0.05. 
the red pulp of the spleen parallels  the quantitative reduction in content of 
splenic alkaline phosphatase activity. Thus it is possible to use measurement 
of splenic alkaline phosphatase activity as an index of myelopoietic activity of 
the spleen. 
Repeated doses of 7, 8, 12-TMBA did not affect the initial levels of alkaline 
phosphatase  activity or myelopoiesis  in  the spleen.  By contrast,  significant 
increases  in  acid  phosphatase  activity  followed  each  dose  of  hydrocarbon 
(Table IV). 
LDH and MDH activity in the spleens of hydrocarbon-treated rats always 
exceeded that  of untreated controls,  but  no  significant  changes in  relative 
proportion of either enzyme occurred (Table IV). 
In normal rat thymus acid phosphatase activity exceeded that of alkaline 
phosphatase by severalfold; and, the activity of MDH normally exceeded that 1294  LEUKEMIA  IN  SPLEEN 
LDH 
of LDH  (Q MDH  -  <  1).  Repeated  pulse-doses  of  7, 8, 12-TMBA did not 
significantly change the level of phosphatase or dehydrogenase enzymes in rat 
thymus. 
DISCUSSION 
In our experiments the  earliest morphological evidence of leukemia elicited 
with 7,  8,  12-TMBA was found in the spleen. Hyperplastic loci of cells indis- 
Fie.,. 5.  Spleen  of untreated control rat age 28 days. Alkaline  phosphatase activity is present 
in endothelium of small blood vessels in malpighian corpuscle (MC) and in myelopoietic  foci 
(arrows) in red pulp. Gomori's alkaline phosphatase reaction counterstained with eosin. X 201). 
tinguishable  from leukemic stem cells,  together with  erythroblastic elements, 
were found in the red pulp especially after the fourth pulse-dose of hydrocarbon. 
These proliferating stem cells formed a  collar around malpighian corpuscles or 
when situated in subcapsular  areas of the spleen,  caused nodule formation in 
the  gross. These hyperplastic nodules bear some resemblance  to the  undiffer- 
entiated  erythropoietic colonies in spleens of lethally  irradiated mice injected 
with isologous bone marrow and  subjected to various procedures  to augment 
or suppress erythropoiesis (24).  The normal immature  rat spleen exhibits con- COLIN  BIRD  AND  CHARLES  HUGGINS  1295 
siderable hemopoietic activity at a  time when  physiological anemia exists; as 
the physiological anemia regresses hemopoietic activity in the spleen diminishes. 
In immature rats which received a  series  of pulse-doses of 7,  8,  12-TMBA, 
normal hemopoietic development was disrupted and physiological anemia per- 
sisted. It is postulated that this anemia may act as a stimulus for hyperplasia 
of nonleukemic erythroblastic stem cells in the spleen which, under hydrocarbon 
influence, may undergo aberrant differentiation with ultimate development of 
stem-cell leukemia. The  relationship between the  early splenic  changes and 
subsequent development of leukemia in other tissues requires further elucida- 
tion. 
A  consistent attribute of rapidly growing cancers,  discovered by Warburg 
(14), is a high rate of glycolysis both in the presence and absence of oxygen. In 
glycolysis, conversion of pyruvate to lactate depends upon the catalytic actions 
• of LDH; considerable evidence has now been adduced which suggests that in 
many cancerous tissues the isoenzyme component of LDH which is best adapted 
functionally for anaerobic metabolism is increased (25). 
Measurement of LDH and MDH activity concurrently was useful. In normal 
LDH 
rat spleen MDH predominated and Q MDH  ~  1, whereas in leukemic spleen 
LDH  _ 
the  reverse  was  true,  Q ~  ~  1.  The  increased  levels  of  LDH  activity 
found in leukemic spleen are  consistent with the anticipated higher glycolytic 
rate of a rapidly growing cancer. 
Pulse-doses  of  hydrocarbon markedly affected  the  normal  growth  of  the 
spleen  and  thymus.  It is  remarkable,  however,  that  only minimal  changes 
occurred in the activity of the critical enzymes measured after each dose of 
hydrocarbon. 
SUMMARY 
An early sign of erythroblastic leukemia in rat was nodule formation in the 
spleen.  Hyperplastic loci  of  stem  cells,  indistinguishable histologically from 
leukemic stem cells, were found in the red pulp whereas the malpighian corpus- 
cles were uninvolved. 
Anemia is a  normal phenomenon in immature rats  and the spleen of the 
prepubertal rat possesses  considerable hemopoietic potential. Pulse-doses of 7, 
8,  12-trimethylbenz(a)anthracene  prevented  the  physiologic  hematological 
development of maturing rats and was associated with subsequent development 
of leukemic stem cells in the red pulp of the spleen. 
Significant enzyme changes were observed in leukemic spleens.  Compared 
with the spleens of normal littermates, the concentration of lactate dehydro- 
genase rose while that of malate dehydrogenase fell; the content of alkaline 
phosphatase rose whereas acid phosphatase fell. Increased alkaline phosphatase 
activity in leukemic spleen was attributed to nonleukemic loci of myelopoiesis. 1296  LEUKEMIA IN  SPLEEN 
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